Coloplast A/S (XSWX:COLOB)
CHF 115 0 (0%) Market Cap: 22.64 Bil Enterprise Value: 25.50 Bil PE Ratio: 40.61 PB Ratio: 11.45 GF Score: 91/100

Q4 2022 Coloplast A/S Earnings Call Transcript

Nov 07, 2022 / 02:00PM GMT
Release Date Price: CHF115
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Coloplast Full Year 2021/2022 Earnings Release Conference Call. (Operator Instructions)

I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you very much, operator. Good afternoon and welcome to our full year '21/'22 conference call. I am joined here by our CFO, Anders Lonning-Skovgaard. And our Investor Relations team will start with a short presentation by Anders and myself. And then we'll do what we usually do, open up for questions. Could I ask you all to turn to Slide #3?

We delivered 6% organic growth and a 31% EBIT margin before special items for the financial year. Return on invested capital after tax and before special items was 27%, impacted by the Atos Medical acquisition.

In Q4, we delivered 5% organic growth and a 30% EBIT margin before special items. I'm satisfied with this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot